Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies

Kidney transplant recipients (KTR) are at increased risk for COVID-19-associated complications. We aimed to describe the evolving epidemiology and outcome of PCR-documented SARS-CoV-2 infection in KTR followed at our institution from March 2020 to May 2022. The primary endpoint was hospitalization f...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadimitriou-Olivgeris, Matthaios, Cipriano, Ana, Guggisberg, Nicolas, Kroemer, Marie, Tschopp, Jonathan, Manuel, Oriol, Golshayan, Dela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576844/
https://www.ncbi.nlm.nih.gov/pubmed/36267693
http://dx.doi.org/10.3389/ti.2022.10721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576844/
https://www.ncbi.nlm.nih.gov/pubmed/36267693
http://dx.doi.org/10.3389/ti.2022.10721

Ejemplares similares